Pomegranates vs Health Claims: Fact or Fiction?

Pomegranates have been scrutinized extensively regarding their potential benefits for conditions such as weight management, diabetes control, chronic obstructive pulmonary disease (COPD), prostate cancer, osteoarthritis, and rheumatoid arthritis. The high-profile legal battle between POM Wonderful,

Pomegranates have been scrutinized extensively regarding their potential benefits for conditions such as weight management, diabetes control, chronic obstructive pulmonary disease (COPD), prostate cancer, osteoarthritis, and rheumatoid arthritis.

The high-profile legal battle between POM Wonderful, a prominent pomegranate juice producer, and the Federal Trade Commission escalated all the way to the U.S. Court of Appeals, with the Supreme Court ultimately declining to review the case. In this pivotal ruling, the judges determined that numerous advertisements from POM Wonderful contained false or misleading statements. The company had promoted medical research suggesting that regular intake of their products could treat, prevent, or lower the risk of serious conditions like heart disease, prostate cancer, and erectile dysfunction. However, the First Amendment does not shield deceptive advertising practices. This decision represented a significant setback for the company's billionaire owners. The court mandated that claims about treating or preventing diseases must be backed by at least one randomized clinical trial to hold any validity.

Examining the broader medical literature on pomegranates reveals numerous review articles highlighting their wide-ranging health advantages, often accompanied by illustrative diagrams depicting the medicinal properties of pomegranates.

Yet, a closer inspection uncovers that these claims frequently rely on research such as investigations into the antiobesity properties of pomegranate leaf extract using mouse models. This raises two key questions: who consumes pomegranate leaves in practice, and how relevant are findings from mice to human health?

When it comes to human weight management, do pomegranates make a difference? A comprehensive analysis of all randomized controlled clinical trials involving humans shows that pomegranate products do not produce any notable changes in body weight, body mass index (BMI), abdominal fat accumulation, or overall body fat percentage among participants assigned to consume them.

Regarding the role of pomegranates in preventing or managing cardiovascular conditions, experts reviewed data from 25 clinical trials. These studies evaluated impacts on cholesterol levels, blood pressure, arterial function, the development of atherosclerotic plaques, and platelet activity. Even the most rigorous trials failed to demonstrate significant benefits.

POM Wonderful even provided funding for a study exploring pomegranate juice's effects on erectile dysfunction, but the results were disappointing, showing no positive outcomes. Similarly, additional research revealed no improvements in diabetes-related biomarkers or any advantages for patients with chronic obstructive pulmonary diseases like emphysema. The company had hoped the juice's antioxidant properties would deliver benefits, but these effects were only observed in vitro, such as in test tubes or petri dishes. Surprisingly, a meta-analysis aggregating data from 11 randomized controlled trials concluded there was no compelling evidence that pomegranate consumption substantially boosts total antioxidant capacity in human blood. This is because some of the most powerful antioxidants in pomegranates do not appear to be absorbed into the human bloodstream effectively. Consequently, pomegranate supplements showed no influence on oxidative stress levels in tissue samples from prostate cancer patients. Naturally, the real question remains whether pomegranates impact the cancer itself.

The most robust evidence purportedly supporting pomegranates' anticancer potential stems from prostate cancer research. Regrettably, initial encouraging findings did not hold up under further scrutiny. For instance, a randomized controlled trial demonstrated that daily pomegranate consumption had no effect on prostate-specific antigen (PSA) levels, which serve as an indicator of tumor advancement. Moreover, a randomized, double-blind, placebo-controlled study revealed virtually no differences in prostate cancer progression rates between treatment and placebo groups.

Researchers had anticipated that the anti-inflammatory effects of pomegranate juice might prove helpful, but these were again limited to in vitro demonstrations. In human subjects, a 2016 meta-analysis of five randomized controlled trials determined that pomegranate juice exerted no meaningful influence on C-reactive protein levels, a critical inflammation indicator. Nevertheless, examining the forest plot from these studies indicates that all five trials showed a trend toward reduced C-reactive protein, with combined data nearly achieving statistical significance.

A more recent meta-analysis from 2020, incorporating seven studies, surpassed the threshold for statistical significance. It reported a notable reduction not only in C-reactive protein but also in two additional inflammatory markers.

These findings suggest that pomegranate juice might indeed assist in managing inflammatory conditions. However, definitive proof requires rigorous testing in clinical settings.

Osteoarthritis is characterized by the progressive breakdown of cartilage that cushions the joints, most commonly affecting the knees. Applying pomegranate extract directly to samples of human osteoarthritic cartilage in laboratory conditions demonstrated protective effects against cartilage degradation. Compared to baseline cartilage breakdown rates, inflammatory agents tripled the damage. Yet, introducing progressively higher concentrations of pomegranate extract progressively mitigated this destruction.

This evidence, however, is confined to petri dish experiments. For pomegranates to benefit joints in living humans, their active compounds must enter the bloodstream and reach the affected areas. Studies have confirmed that cartilage-protective elements from pomegranates are bioavailable, at least in animal models like rabbits. This opens the door to pomegranates serving as a safe, non-toxic alternative to conventional medications, which often carry side effects. The critical question is whether they deliver real-world efficacy.

The inaugural clinical trial on pomegranate juice for osteoarthritis lacked a placebo control, instead assigning participants randomly to juice or no intervention. Those consuming the juice experienced reduced stiffness and improved physical function, but the differences were not statistically superior to the no-treatment group.

On the verge of dismissing pomegranates entirely, attention turned to a study on hydrolyzable tannins-rich pomegranate extract and its potential to curb inflammation and joint damage in rheumatoid arthritis. Disappointingly, this research originated from POM Wonderful and utilized a mouse model to induce joint damage.

An open-label trial involved patients with active rheumatoid arthritis who were fully aware of receiving pomegranate extract daily. Of the eight participants, six completed the regimen and reported fewer tender joints. Without a control group, however, it remains unclear whether the extract was responsible for the improvements.

At last, a properly designed randomized, double-blind, placebo-controlled trial emerged. Participants were divided evenly: half received pomegranate extract unknowingly, while the other half got a placebo equivalent to a sugar pill. Results showed marked improvements in swollen joints, tender joints, pain levels, disease activity scores, health assessment questionnaires, and morning stiffness compared to the placebo group. For individuals battling rheumatoid arthritis, incorporating pomegranates into the diet appears promising. Rather than relying on supplements, whole fruit is preferable. Testing of 19 commercial pomegranate supplements revealed that most contained little to no actual pomegranate; only six proved authentic.